These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3355714)

  • 21. Erythrocyte 2,3-DPG, ATP and oxygen affinity in hemodialysis patients.
    Ninness JR; Kimber RW; McDonald JW
    Can Med Assoc J; 1974 Oct; 111(7):661-5. PubMed ID: 4413276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between hematocrit and erythrocyte magnesium concentration in patients on regular hemodialysis.
    Gonella M; Betti G; Buzzigoli G; Bartolini V
    Nephron; 1979; 24(3):134-7. PubMed ID: 492423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hemodialysis on plasma and erythrocyte phenylalanine levels in end-stage kidney patients.
    St epniewski M; Smoleński O; Kopeć J; Kuźniewski M
    Nephron; 1985; 39(3):189-93. PubMed ID: 3974781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure.
    Durak I; Akyol O; Başeşme E; Canbolat O; Kavutçu M
    Nephron; 1994; 66(1):76-80. PubMed ID: 8107958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia.
    Chauhan DP; Gupta PH; Nampoothiri MR; Singhal PC; Chugh KS; Nair CR
    Clin Chim Acta; 1982 Aug; 123(1-2):153-9. PubMed ID: 6749335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication.
    Zachée P; Ferrant A; Daelemans R; Goossens W; Boogaerts MA; Lins RL
    Nephron; 1995; 71(3):343-9. PubMed ID: 8569984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients.
    Ross EA; Koo LC; Moberly JB
    Am J Kidney Dis; 1997 Oct; 30(4):489-94. PubMed ID: 9328362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis.
    Jung BC; Laidlaw SA; Kopple JD
    Am J Kidney Dis; 1991 Jul; 18(1):74-9. PubMed ID: 2063858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of reduced glutathione by HPLC-UV in erythrocytes of hemodialysis patients.
    Garcia SC; Schott K; Charão M; Moro A; Bulcão R; Grotto D; Valentini J; Bohrer D; Cardoso S; Pomblum V
    Biomed Chromatogr; 2008 May; 22(5):460-8. PubMed ID: 18205143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis.
    Wlodek PJ; Iciek MB; Milkowski A; Smolenski OB
    Clin Chim Acta; 2001 Feb; 304(1-2):9-18. PubMed ID: 11165194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
    Westhuyzen J; Saltissi D; Stanbury V
    Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair zinc compared with plasma zinc in uremic patients before and during regular hemodialysis.
    Mountokalakis T; Dakanalis D; Boukis D; Virvidakis K; Voudiklari S; Koutselinis A
    Clin Nephrol; 1979 Nov; 12(5):206-9. PubMed ID: 509794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic and prognostic value of antioxidant enzyme assay in erythrocytes of patients with end stage renal disease treated with hemodialysis].
    Vavilova TP; Geva ON; Pushkina AV; Tkachev GA; Koretskaia NA
    Biomed Khim; 2006; 52(2):219-22. PubMed ID: 16805395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of erythrocytes in the deperoxidative processes in people on hemodialysis.
    Biasioli S; Schiavon R; De Fanti E; Cavalcanti G; Giavarina D
    ASAIO J; 1996; 42(5):M890-4. PubMed ID: 8945013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin.
    Zachara BA; Adamowicz A; Trafikowska U; Trafikowska A; Manitius J; Nartowicz E
    J Trace Elem Med Biol; 2001; 15(4):201-8. PubMed ID: 11846008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell metabolism in renal failure--the effect of dialysis.
    Chu P; Cadley M; Bellingham AJ
    Clin Lab Haematol; 1985; 7(1):1-5. PubMed ID: 4006401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients.
    Canestrari F; Buoncristiani U; Galli F; Giorgini A; Albertini MC; Carobi C; Pascucci M; Bossù M
    Clin Chim Acta; 1995 Jan; 234(1-2):127-36. PubMed ID: 7758212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
    Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
    Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients.
    DeBari VA; Frank O; Baker H; Needle MA
    Am J Clin Nutr; 1984 Mar; 39(3):410-5. PubMed ID: 6695840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients.
    Huang KC; Yang CC; Hsu SP; Lee KT; Liu HW; Morisawa S; Otsubo K; Chien CT
    Kidney Int; 2006 Jul; 70(2):391-8. PubMed ID: 16760903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.